Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion

被引:35
作者
Domanovits, H
Schillinger, M
Thoennissen, J
Nikfardjam, M
Janata, K
Brunner, M
Laggner, AN
机构
[1] Univ Vienna, Sch Med, Dept Emergency Med, Vienna Gen Hosp, A-1090 Vienna, Austria
[2] Univ Vienna, Sch Med, Dept Cardiol, Vienna Gen Hosp, A-1090 Vienna, Austria
[3] Univ Vienna, Sch Med, Dept Clin Pharmacol, Vienna Gen Hosp, A-1090 Vienna, Austria
关键词
atrial fibrillation/flutter; electrical cardioversion; emergency department; intravenous ibutilide; safety;
D O I
10.1016/S0300-9572(00)00180-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Safety and effectiveness are the goals in treating patients with arrhythmias. In an open prospective study, we observed the efficacy and safety of up to 2 mg intravenous ibutilide, a new class III antiarrhythmic agent in haemodynamically stable patients presenting in the emergency department (ED) with symptoms of recent-onset (< 48 h) atrial fibrillation/flutter. Arrhythmia termination within 90 min, haemodynamic parameters and proarrhythmic effects were assessed. Non-responders to the ibutilide infusion underwent external electrical cardioversion. We included 51 patients. In 31 patients therapeutic intervention with intravenous ibutilide was successful within 90 min (61%). In another seven patients conversion to sinus rhythm occurred after 90 min without any other intervention (14%). Blood pressure remained stable and no relevant proarrhythmic effects were observed. The 13 patients who did not respond to ibutilide treatment underwent successful external electrical cardioversion. The overall conversion rate was 100%. Forty-seven patients (92%) were discharged within a median of 9 h and managed as outpatients. In conclusion, in haemodynamically stable patients with recent-onset atrial fibrillation/flutter intravenous ibutilide and external electrical cardioversion for conversion to sinus rhythm turned out to be effective and safe. The short duration of admission makes this strategy attractive for use in the ED. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 37 条
[1]   Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation [J].
Abi-Mansour, P ;
Carberry, PA ;
McCowan, RJ ;
Henthorn, RW ;
Dunn, GH ;
Perry, KT .
AMERICAN HEART JOURNAL, 1998, 136 (04) :632-642
[2]   Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction [J].
Anderson, JL ;
Karagounis, LA ;
Califf, RM .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (01) :1-8
[3]  
BIALY D, 1992, Journal of the American College of Cardiology, V19, p41A
[4]  
BJERKELUND C, 1968, ACTA MED SCAND, V184, P481
[5]   ANTIARRHYTHMIC AND ELECTROPHYSIOLOGIC EFFECTS OF IBUTILIDE IN A CHRONIC CANINE MODEL OF ATRIAL-FLUTTER [J].
BUCHANAN, LV ;
TURCOTTE, UM ;
KABELL, GG ;
GIBSON, JK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (01) :10-14
[6]  
CAPUCCI A, 1995, CIRCULATION, V92, P1
[7]   MANAGEMENT OF ATRIAL TACHYARRHYTHMIAS IN THE CRITICALLY ILL - A COMPARISON OF INTRAVENOUS PROCAINAMIDE AND AMIODARONE [J].
CHAPMAN, MJ ;
MORAN, JL ;
OFATHARTAIGH, MS ;
PEISACH, AR ;
CUNNINGHAM, DN .
INTENSIVE CARE MEDICINE, 1993, 19 (01) :48-52
[8]  
Connors S, 1997, CAN J CARDIOL, V13, pA19
[9]   Sustained ventricular tachycardia in the emergency department [J].
Domanovits, H ;
Paulis, M ;
Nikfardjam, M ;
Holzer, M ;
Stühlinger, HG ;
Hirschl, MM ;
Laggner, AN .
RESUSCITATION, 1999, 42 (01) :19-25
[10]   REVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION TO SINUS RHYTHM BY INTRAVENOUS FLECAINIDE [J].
DONOVAN, KD ;
DOBB, GJ ;
COOMBS, LJ ;
LEE, KY ;
WEEKES, JN ;
MURDOCK, CJ ;
CLARKE, GM .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (02) :137-141